Form 483

Apozeal Pharmaceuticals Inc. Form 483, 2019-04-09

FDA issued a Form 483 to Apozeal Pharmaceuticals Inc. on 2019-04-09 with 8 public-safe observations.

483· Form 483 issuedHuman Drugs8 observations

Apozeal Pharmaceuticals Inc. · Levittown, United States · Issued April 9, 2019

Overview

  • 8 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

9 Apr 2019
21 CFR 211.110(b)

In-process conformity - examination, sample testing

Cited by Christina K Theodorou, Lisa B Orr, Dandan Wang

9 Apr 2019
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Christina K Theodorou, Lisa B Orr, Dandan Wang

9 Apr 2019
21 CFR 211.160(b)(3)

Acceptance of drug products

Cited by Christina K Theodorou, Lisa B Orr, Dandan Wang

9 Apr 2019
21 CFR 211.192

Extent of discrepancy, failure investigations

Cited by Christina K Theodorou, Lisa B Orr, Dandan Wang

9 Apr 2019
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Christina K Theodorou, Lisa B Orr, Dandan Wang

Inspected site

APApozeal Pharmaceuticals Inc.Levittown, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.110(b)Cited across public-safe Form 483 observations1x
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)(3)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere